Drug Information

Drug General Information
Drug ID
D0W0TW
Former ID
DCL001235
Drug Name
S-349572
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 3 [551686]
Company
Shionogi & GlaxoSmithKline
Structure
Download
2D MOL

3D MOL
Formula
C20H19F2N3O5
Canonical SMILES
CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)<br />F)F)O
InChI
1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1
InChIKey
RHWKPHLQXYSBKR-BMIGLBTASA-N
PubChem Compound ID
54726191
PubChem Substance ID
96100998, 123055423, 124361075, 124361082, 124361088, 135268073, 135273443, 135626786, 136340316, 136349541, 136367672, 136920429, 144115916, 152258477, 160647312, 160693271, 162011364, 162038052, 162202774, 163677014, 164043525, 164193963, 164347381, 170484068, 170484069, 170484070, 170503405, 174007466, 174525979, 175427161, 178103937, 184812380, 189622844, 198935766, 198993556, 223382143, 223705174, 226460906, 242590891, 248390482, 250184664, 252110159, 252224388, 252451605
Target and Pathway
Target(s) HIV integrase Target Info Inhibitor [532651], [551686]
References
Ref 551686Clinical pipeline report, company report or official report of Shionogi (2011).
Ref 5326512013 FDA drug approvals. Nat Rev Drug Discov. 2014 Feb;13(2):85-9.
Ref 551686Clinical pipeline report, company report or official report of Shionogi (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.